Suppr超能文献

孕期使用抗抑郁药与儿童自闭症谱系障碍之间的关联:一项基于日本索赔数据的回顾性队列研究。

Association between antidepressant use during pregnancy and autism spectrum disorder in children: a retrospective cohort study based on Japanese claims data.

作者信息

Yamamoto-Sasaki Madoka, Yoshida Satomi, Takeuchi Masato, Tanaka-Mizuno Sachiko, Ogawa Yusuke, Furukawa Toshiaki A, Kawakami Koji

机构信息

1Department of Pharmacoepidemiology, Graduate School of Medicine and Public Health, Kyoto University, Yoshidakonoe-cho Sakyo-ku, Kyoto, 606-8501 Japan.

2Department of Medical Statistics, Shiga University of Medical Science, Setatsukinowacho Otsu, Shiga, 520-2121 Japan.

出版信息

Matern Health Neonatol Perinatol. 2019 Jan 10;5:1. doi: 10.1186/s40748-018-0096-y. eCollection 2019.

Abstract

BACKGROUND

Studies using data from Western countries have raised concerns that treating pregnant women with antidepressants may increase the risk of autism spectrum disorders (ASDs) in their offspring. However, to date, the studies are inconclusive. We therefore examined the association between antidepressant use and ASD using claims data collected in Japan.

METHODS

This retrospective cohort study was based on claims data from mothers and their children from January 2005 to July 2014, obtained from the Japan Medical Data Center. The information from mothers and children was linked using the family identification code. Information on antidepressant prescriptions during pregnancy was extracted from the database. To collect information on ASD, children for whom data were available 24 months or more after birth were followed up from birth through July 2014 or up until their withdrawal from the database. To ensure appropriate diagnosis of ASD, mother-child pairs where the children's data did not cover the 24 months after birth or pairs where children had a diagnosis of ASD within only 23 months after birth were excluded from the study cohort. We used logistic regression analyses to evaluate the association between antidepressant use during pregnancy and the children's ASD diagnosis. All statistical analyses were performed using IBM SPSS (Statistical Package for the Social Sciences) Statistics ver. 21.0.

RESULTS

Of the 53,864 eligible mother-child pairs, 26,925 met the study criteria. Crude analysis showed that the ASD prevalence in children was significantly higher with any antidepressant use than with non-use (odds ratio [OR], 2.32; 95% confidence interval [CI], 1.08, 4.95). However, when the analysis was adjusted for the confounding effect of maternal depression during pregnancy, statistical significance was lost (OR, 0.76; CI, 0.27, 2.18).

CONCLUSIONS

After adjustment for confounders, we found no significant association between antidepressant use during pregnancy and ASD in children in Japan. This result provides additional evidence to support the idea that antidepressant use during pregnancy itself is not associated with an increase in ASD in children. In addition, this represents the first evidence based on Asian data.

摘要

背景

利用西方国家数据开展的研究引发了人们对孕妇使用抗抑郁药可能增加其后代患自闭症谱系障碍(ASD)风险的担忧。然而,迄今为止,这些研究尚无定论。因此,我们利用在日本收集的理赔数据,研究了抗抑郁药使用与自闭症谱系障碍之间的关联。

方法

这项回顾性队列研究基于2005年1月至2014年7月期间从日本医疗数据中心获取的母亲及其子女的理赔数据。母亲和子女的信息通过家庭识别码进行关联。从数据库中提取孕期抗抑郁药处方信息。为收集自闭症谱系障碍的信息,对出生后24个月或更长时间有数据的儿童从出生开始随访至2014年7月,或直至其退出数据库。为确保对自闭症谱系障碍的准确诊断,研究队列排除了儿童数据未涵盖出生后24个月的母婴对,或儿童仅在出生后23个月内被诊断为自闭症谱系障碍的母婴对。我们使用逻辑回归分析来评估孕期使用抗抑郁药与儿童自闭症谱系障碍诊断之间的关联。所有统计分析均使用IBM SPSS(社会科学统计软件包)统计软件版本21.0进行。

结果

在53,864对符合条件的母婴对中,26,925对符合研究标准。粗分析显示,使用任何抗抑郁药的儿童自闭症谱系障碍患病率显著高于未使用者(优势比[OR],2.32;95%置信区间[CI],1.08,4.95)。然而,在对孕期母亲抑郁的混杂效应进行调整后,统计学显著性消失(OR,0.76;CI,0.27,2.18)。

结论

在对混杂因素进行调整后,我们发现日本孕期使用抗抑郁药与儿童自闭症谱系障碍之间无显著关联。这一结果为孕期使用抗抑郁药本身与儿童自闭症谱系障碍增加无关这一观点提供了更多证据。此外,这是基于亚洲数据的首个证据。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验